267196 Women's Recall of Recommended Client-Directed Interventions to Promote Breast Cancer Screening: A National Survey

Monday, October 29, 2012

Brandie Yancy, MPH, CHES , Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA
Jacqueline Miller, MD , Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA
Djenaba Joseph, MD, MPH , Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA
Sue Sabatino, MD, MPH , Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA
James C. Hersey, PhD , RTI International, Washington, DC
Kristin Arnold, MSPH , RTI International, Washington, DC
Bridget Kelly, PhD, MPH , Health Communication, RTI International, Washington, DC
Daniel Dench, BA , Public Health Policy Research Program, RTI International, Research Triangle Park, NC
Marjorie Margolis, BA , Health, Social & Economics Research Division, RTI International, Washington, DC
Tara Zhang, MPH , UC Berkeley, School of Public Health, Oakland, CA
BACKGROUND: Current mammography rates in the U.S. (75%) are below the Healthy People 2020 goal of 81%. The Guide to Community Preventive Services recommends evidence-based client-directed interventions to increase breast cancer screening rates (client reminders (CR); small media (SM); one-on-one (OE) and group education (GE); reduction of out-of-pocket costs (ROPC); and reduction of structural barriers (RSB)). This study examined women's receipt of interventions to promote mammography within the past 12 months. METHODS: In 2010, the Community Supports for Cancer Screening Survey was conducted among women aged 40 -74 using random-digit-dial and a web-based panel. Low-income and minority populations were oversampled. Data were weighted for analysis. Logistic regression was used to identify factors associated with the receipt of interventions adjusting for sociodemographic, health history and health care access. RESULTS: Of 2,514 women surveyed, >90% reported receiving >1 recommended interventions. RSB was most common (79%) followed by OE, CR, SM (43-38%), ROPC (24%) and GE (2%). Screening availability outside of work hours was the most common form of RSB. After adjustment, interventions were significantly less likely reported among women under age 50, between 251-400% of the federal poverty level, and those with no insurance, no provider, or, no family history of cancer. Hispanics were more likely to report receiving an intervention. DISCUSSION: These findings demonstrate that most women aged 40-74 recalled receiving ≥1 recommended interventions to promote mammography screening; however, opportunities exist to further implement evidence-based targeted interventions to increase breast cancer screening.

Learning Areas:
Administer health education strategies, interventions and programs
Chronic disease management and prevention
Implementation of health education strategies, interventions and programs
Public health or related laws, regulations, standards, or guidelines

Learning Objectives:
Describe evidenced-based interventions to promote screening for breast cancer. Discuss women’s receipt of recommended evidence based client-directed interventions among various subpopulations.

Keywords: Breast Cancer Screening, Cancer Prevention

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a member of the program evaluation team of which I support project officers with program oversight and technical assistance for the National Breast and Cervical Cancer Early Detection Program and the Colorectal Cancer Control Grantees. I am a qualified public health researcher trained to conduct evaluability assessments, focus groups, surveys, interviews, comprehensive literature reviews, quantitative and qualitative analyses, and synthesizing results for summary and detailed reports.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.